Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumab
-
Altmetric Citations
Gillies, Mark C; Campain, Anna; Walton, Richard; Simpson, Judy M; Arnold, Jennifer J; Guymer, Robyn H; McAllister, Ian L; Hunyor, Alex P; Essex, Rohan; Morlet, Nigel; Barthelmes, Daniel
Description
PURPOSE: To characterize in more detail routine treatment patterns of intravitreal ranibizumab for neovascular age-related macular degeneration (nAMD), we analyzed the length of time and the number of injections required until lesions with choroidal neovascularization (CNV) were first graded inactive. DESIGN: Database observational study. PARTICIPANTS: Treatment-naïve eyes receiving predominantly ranibizumab for nAMD in routine clinical practice that were tracked in the Fight Retinal Blindness!...[Show more]
Collections | ANU Research Publications |
---|---|
Date published: | 2015-03 |
Type: | Journal article |
URI: | http://hdl.handle.net/1885/13274 |
Source: | Ophthalmology |
DOI: | 10.1016/j.ophtha.2014.10.001 |
Download
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.
Updated: 17 November 2022/ Responsible Officer: University Librarian/ Page Contact: Library Systems & Web Coordinator